SPRB 241220 1.50P (SPRB241220P1500) Stock Options, News & Quotes

US OptionsDetailed Quotes

SPRB241220P1500

Watchlist

0.00
0.000.00%

15min DelayClose Nov 29 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Congenital Adrenal Hyperplasia Landscape Research 2024: Comprehensive Insights About 8+ Pipeline Drugs Featuring Neurocrine Biosciences, Spruce Biosciences, Lundbeck, and HBM Alpha Therapeutics
Yahoo FinanceNov 21 04:06 ET
Spruce Biosciences Faces Nasdaq Delisting Threat: Can a Reverse Stock Split Save Its Market Presence?
TipRanksNov 13 01:01 ET
Spruce Biosciences | 10-Q: Q3 2024 Earnings Report
SECNov 12 11:47 ET · Announcements
Spruce Biosciences | 8-K: Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
SECNov 12 09:24 ET
RBC Capital Sticks to Their Hold Rating for Spruce Biosciences (SPRB)
TipRanksNov 12 06:38 ET · Ratings
Spruce Biosciences Reports Q3 EPS (21c), Consensus (24c)
TipRanksNov 11 08:11 ET

Comments

73372627

Aug 10 13:31

$Zebra Technologies (ZBRA.US)$ and the true of the Spruce analysis

I will never undestend why this company is not investigated for manipulating the market on theirs own interest.
Let's go see why such investigation is neccessary and I hope Zebra will complain.
Spruce it is an Short-selling company which allways made negative reports or analysis in order to influence the market for theyr's own profit. Parallel with Short-selling they are also in real estate managment in New York where they loose b...

Jaguar8

Jun 4 06:13

NEWS

$Spruce Biosciences (SPRB.US)$
Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)
Spruce Biosciences (Nasdaq: SPRB) and HMNC Brain Health announced a strategic collaboration to develop a treatment for Major Depressive Disorder (MDD) using Spruce's tildacerfont and HMNC's Cortibon Genetic Selection Tool. The Phase 2 study is set to begin in Q4 2024. Should the study be successful, Spruce has the option to acquire e...

Meltyy

May 22 02:52

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...

MangoXoXo

Mar 28 15:18

$Spruce Biosciences (SPRB.US)$ 👀

hard-working Camel_4

Mar 25 03:02

$Spruce Biosciences (SPRB.US)$ 0.952!?